Bay Area Medical Device Companies Doing Well
December 20, 2014
By Andrew Hoglund

There were several medical device companies from the Bay Area that made the news this week. A small company in South San Francisco, diaDexus, received FDA 510(k) clearance for its PLAC Activity test to assess coronary heart disease risk. The new test checks the activity of Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) in human plasma and serum. The enzyme assay is based on a National Institutes of Health-funded study of 4,500 people with no prior history of heart problems which found that elevated Lp-PLA2 activity levels are associated with a much greater

Read More

Recalls and Scandals Commanded November Headlines
December 8, 2014
By Aneel Dhaliwal

While we all enjoyed the November month by taking in the beautiful Fall colors and ultimately stuffing our faces with turkey and mashed potatoes, the medical device world was having a less than merry time. Recalls and scandals commanded the headlines keeping us folks wide-eyed with interest. Some of the biggest news related to recalls came from Hospira and Stryker. Hospira was struck with its fifth GemStar Infusion System related recall in 3 years. The FDA recalled Hospira’s GemStar device for potentially failing to deliver electric power to the pump.

Read More

Medical Device Startups Making A Name For Themselves
December 6, 2014
By Andrew Hoglund

From receiving large amounts of funds to gaining FDA clearance, it was an exciting week for new developing companies. DBV Technologies, located in Bagneux, France, has become very popular in the last year. They are creating a patch that will treat peanut allergies, which is great news for my colleague Aneel who suffers from nut allergies. Named the Viaskin patch, it helps lower the risk of an allergic reaction to an accidental exposure of peanuts. The company went public back in 2012 and its stock has nearly quadrupled just this

Read More